Indeed, simultaneous knockout of the ATG7 gene in MSCs and AML cells enhances the effectiveness of treatment with cytarabine compared to knockout of ATG7 in AML cells only (Piya et al. 2016). The gene discussed is ATG7; the disease is acute myeloid leukemia.